Waters (WAT) Cash from Financing Activities (2009 - 2026)
Waters (WAT) recorded quarterly Cash from Financing Activities of -$213.0 million in Q2 2026, down 6484.89% quarter-over-quarter from $3.3 million in Q4 2025, and down 23.12% on a YoY basis from -$277.1 million in Q2 2025.
Waters (WAT) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Waters' Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$213.0 million for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 23.12% year-over-year to -$213.0 million; the TTM figure through Apr 2026 stood at -$277.2 million (up 52.0% YoY), while the FY2025 annual figure was -$237.2 million, up 65.95% from the prior year.
- Cash from Financing Activities was -$213.0 million for Q2 2026 at Waters, down from $3.3 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $3.3 million in Q4 2025 to a low of -$292.2 million in Q1 2024.
- Historically, Cash from Financing Activities has averaged -$125.2 million across 5 years, with a median of -$122.0 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities tumbled 55.81% in 2024, then soared 101.72% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at -$111.4 million in 2022, then dropped by 17.09% to -$130.5 million in 2023, then plunged by 48.35% to -$193.6 million in 2024, then jumped by 101.72% to $3.3 million in 2025, then plunged by 6484.89% to -$213.0 million in 2026.
- The last three Cash from Financing Activities figures came in at -$213.0 million (Q2 2026), $3.3 million (Q4 2025), and -$66.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | -152.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -213.00 Mn |
| Apr 4, 2026 | -213.00 Mn |
| Dec 31, 2025 | 3.34 Mn |
| Dec 31, 2025 | 3.34 Mn |
| Sep 27, 2025 | -66.27 Mn |
| Sep 27, 2025 | -66.27 Mn |
| Jun 28, 2025 | -1.28 Mn |
| Jun 28, 2025 | -1.28 Mn |
| Mar 29, 2025 | -173.00 Mn |
| Mar 29, 2025 | -173.00 Mn |
| Dec 31, 2024 | -193.58 Mn |
| Dec 31, 2024 | -193.58 Mn |
| Sep 28, 2024 | -176.88 Mn |
| Sep 28, 2024 | -176.88 Mn |
| Jun 29, 2024 | -34.04 Mn |
| Jun 29, 2024 | -34.04 Mn |
| Mar 30, 2024 | -292.18 Mn |
| Mar 30, 2024 | -292.18 Mn |
| Dec 31, 2023 | -130.49 Mn |
| Dec 31, 2023 | -130.49 Mn |